Deltex Medical Proposes Delisting from London's AIM

Dow Jones

Jan 21, 2025

By Najat Kantouar

Deltex Medical said it would propose delisting from London's Alternative Investment Market at its next general meeting.

The medical technology group said Tuesday that it would seek approval for the delisting at its general shareholder meeting on Feb. 12.

The group has so far received letters of intent and irrevocable undertakings in favor of the proposal representing around 53.8% of the company's share capital, it said.

The cancellation is conditional upon the approval of at least 75% of the votes. If the proposal is passed at the general meeting, it will become effective on Feb. 21, Deltex said.

Write to Najat Kantouar at najat.kantouar@wsj.com

(END) Dow Jones Newswires

January 21, 2025 03:22 ET (08:22 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2505521004"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2505521004\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2505521004?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-21 16:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2505521004","market":"us","top_or_hot":-1,"title":"Deltex Medical Proposes Delisting from London's AIM","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Najat Kantouar \n</p>\n<pre>\n \n</pre>\n<p>\n   Deltex Medical said it would propose delisting from London's Alternative Investment Market at its next general meeting. \n</p>\n<p>\n   The medical technology group said Tuesday that it would seek approval for the delisting at its general shareholder meeting on Feb. 12. \n</p>\n<p>\n  The group has so far received letters of intent and irrevocable undertakings in favor of the proposal representing around 53.8% of the company's share capital, it said. \n</p>\n<p>\n  The cancellation is conditional upon the approval of at least 75% of the votes. If the proposal is passed at the general meeting, it will become effective on Feb. 21, Deltex said. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Najat Kantouar at najat.kantouar@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 21, 2025 03:22 ET (08:22 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Deltex Medical Proposes Delisting from London's AIM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDeltex Medical Proposes Delisting from London's AIM\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-21 16:22</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Najat Kantouar \n</p>\n<pre>\n \n</pre>\n<p>\n   Deltex Medical said it would propose delisting from London's Alternative Investment Market at its next general meeting. \n</p>\n<p>\n   The medical technology group said Tuesday that it would seek approval for the delisting at its general shareholder meeting on Feb. 12. \n</p>\n<p>\n  The group has so far received letters of intent and irrevocable undertakings in favor of the proposal representing around 53.8% of the company's share capital, it said. \n</p>\n<p>\n  The cancellation is conditional upon the approval of at least 75% of the votes. If the proposal is passed at the general meeting, it will become effective on Feb. 21, Deltex said. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Najat Kantouar at najat.kantouar@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 21, 2025 03:22 ET (08:22 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AIM","symbol_name":"AIM ImmunoTech Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2505521004","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2505521004","pubTimestamp":1737447720,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Deltex Medical said it would propose delisting from London's Alternative Investment Market at its next general meeting.The medical technology group said Tuesday that it would seek approval for the delisting at its general shareholder meeting on Feb. 12.The group has so far received letters of intent and irrevocable undertakings in favor of the proposal representing around 53.8% of the company's share capital, it said.The cancellation is conditional upon the approval of at least 75% of the votes. If the proposal is passed at the general meeting, it will become effective on Feb. 21, Deltex said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AIM":"AIM ImmunoTech Inc.","BK4139":"生物科技","BK4557":"大麻股"},"translate_title":"Deltex Medical提议从伦敦AIM退市","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AIM":1},"content_text":"By Najat Kantouar \n\n\n \n\n\n   Deltex Medical said it would propose delisting from London's Alternative Investment Market at its next general meeting. \n\n\n   The medical technology group said Tuesday that it would seek approval for the delisting at its general shareholder meeting on Feb. 12. \n\n\n  The group has so far received letters of intent and irrevocable undertakings in favor of the proposal representing around 53.8% of the company's share capital, it said. \n\n\n  The cancellation is conditional upon the approval of at least 75% of the votes. If the proposal is passed at the general meeting, it will become effective on Feb. 21, Deltex said. \n\n\n \n\n\n  Write to Najat Kantouar at najat.kantouar@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 21, 2025 03:22 ET (08:22 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}